We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T Turnover 6.4%
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+695.64%
AUM
$254B
AUM Growth
+$10.5B
Cap. Flow
+$4.16B
Cap. Flow %
1.64%
Top 10 Hldgs %
15.87%
Holding
4,218
New
134
Increased
2,755
Reduced
887
Closed
134
Avg Time Held
3.2 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.9 years

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$213M
2
MO icon
Altria Group
MO
+$206M
3
XOM icon
ExxonMobil
XOM
+$105M
4
MSFT icon
Microsoft
MSFT
+$86.8M
5
META icon
Meta Platforms (Facebook)
META
+$75.5M

Sector Composition

Rank Sector Weight
1 Technology 16.07%
2 Financials 16.07%
3 Healthcare 14.35%
4 Industrials 10.62%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CRDF icon
3651
Cardiff Oncology
CRDF
$75.5M
$188K ﹤0.01%
2,081
-661
-24% -$42.6K
2013 Q2
16 quarters
CNSY icon
3652
Cerenome
CNSY
$14.3M
$188K ﹤0.01%
+1
New +$202K
2013 Q2
16 quarters
OREX
3653
DELISTED
Orexigen Therapeutics, Inc.
OREX
$186K ﹤0.01%
64,228
-1,892
-3% -$5.67K
2013 Q2
16 quarters
VDTH
3654
DELISTED
Videocon d2h Limited
VDTH
$185K ﹤0.01%
19,046
-4,490
-19% -$47K
2015 Q3
7 quarters
NOA icon
3655
North American Construction
NOA
$308M
$184K ﹤0.01%
42,395
-32,814
-44% -$153K
2017 Q1
1 quarter
UBS icon
3656
UBS Group
UBS
$146B
$184K ﹤0.01%
10,839
– –
2014 Q4
10 quarters
XWEL icon
3657
XWELL
XWEL
$7.45M
$184K ﹤0.01%
93
– –
2016 Q2
4 quarters
AWRE icon
3658
Aware
AWRE
$19.2M
$183K ﹤0.01%
35,720
-3,459
-9% -$16.5K
2013 Q2
16 quarters
MFIC icon
3659
MidCap Financial Investment
MFIC
$700M
$183K ﹤0.01%
9,563
+113
+1% +$2.2K
2016 Q4
2 quarters
XCO
3660
DELISTED
Exco Resources
XCO
$183K ﹤0.01%
69,169
-15,639
-18% -$92.5K
2013 Q2
16 quarters
SB icon
3661
Safe Bulkers
SB
$913M
$182K ﹤0.01%
+79,847
New +$176K
2017 Q2
0 quarters
EIGR
3662
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$182K ﹤0.01%
770
-303
-28% -$68.8K
2016 Q2
4 quarters
EGLT
3663
DELISTED
Egalet Corporation
EGLT
$182K ﹤0.01%
76,800
-38,347
-33% -$122K
2014 Q1
13 quarters
ELOS
3664
DELISTED
Syneron Medical Ltd
ELOS
$182K ﹤0.01%
16,633
-1,625
-9% -$17.8K
2014 Q4
10 quarters
IO
3665
DELISTED
ION Geophysical Corporation
IO
$182K ﹤0.01%
42,046
– –
2013 Q2
16 quarters
CLRO icon
3666
ClearOne Inc
CLRO
$8.29M
$180K ﹤0.01%
1,274
-161
-11% -$23.9K
2014 Q1
13 quarters
NEWT icon
3667
NewtekOne
NEWT
$316M
$180K ﹤0.01%
+11,111
New +$186K
2017 Q2
0 quarters
REED icon
3668
DELISTED
Reeds, Inc. Common Stock
REED
$180K ﹤0.01%
1,475
– –
2013 Q2
16 quarters
PSO icon
3669
Pearson
PSO
$10.7B
$179K ﹤0.01%
19,968
-469
-2% -$4.08K
2013 Q4
14 quarters
SAUC
3670
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$179K ﹤0.01%
68,936
+23,248
+51% +$66.4K
2013 Q3
15 quarters
NNC
3671
DELISTED
Nuveen North Carolina Quality Municipal Income Fund
NNC
$179K ﹤0.01%
+13,487
New +$178K
2017 Q2
0 quarters
GTHX icon
3672
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$178K ﹤0.01%
+10,220
New +$179K
2017 Q2
0 quarters
BLVD
3673
DELISTED
Boulevard Acquisition Corp. II Class A Common Stock
BLVD
$178K ﹤0.01%
17,815
-6,030
-25% -$60.3K
2017 Q1
1 quarter
HMY icon
3674
Harmony Gold Mining
HMY
$10.6B
$177K ﹤0.01%
107,395
+45,767
+74% +$98.2K
2017 Q1
1 quarter
VIV icon
3675
Telefônica Brasil
VIV
$19.6B
$176K ﹤0.01%
+13,083
New +$188K
2017 Q2
0 quarters

Similar funds

Geode Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
  • Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
  • Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
  • Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
  • Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
  • Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
  • Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.